Applied Genetic Technologies Corporation
AGTC · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $325 | $500 | $2,453 | $41,692 |
| % Growth | -35% | -79.6% | -94.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $325 | $500 | $2,453 | $41,692 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $49,515 | $44,400 | $35,778 | $33,183 |
| G&A Expenses | $16,985 | $14,551 | $13,617 | $12,859 |
| SG&A Expenses | $16,985 | $14,551 | $13,617 | $12,859 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $66,500 | $58,951 | $49,395 | $46,042 |
| Operating Income | -$66,269 | -$58,451 | -$46,942 | -$4,350 |
| % Margin | -20,390.5% | -11,690.2% | -1,913.7% | -10.4% |
| Other Income/Exp. Net | -$2,575 | -$1,486 | $1,133 | $2,455 |
| Pre-Tax Income | -$68,750 | -$59,937 | -$45,809 | -$1,895 |
| Tax Expense | $2,674 | -$2,108 | $83 | $76 |
| Net Income | -$71,424 | -$57,829 | -$45,892 | -$2,006 |
| % Margin | -21,976.6% | -11,565.8% | -1,870.9% | -4.8% |
| EPS | -1.59 | -1.77 | -2.17 | -0.11 |
| % Growth | 10.2% | 18.4% | -1,872.7% | – |
| EPS Diluted | -1.59 | -1.77 | -2.17 | -0.11 |
| Weighted Avg Shares Out | 45,031 | 32,756 | 21,102 | 18,157 |
| Weighted Avg Shares Out Dil | 45,031 | 32,756 | 21,102 | 18,157 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,674 | $1,506 | $0 | $0 |
| Depreciation & Amortization | $1,512 | $1,460 | $1,335 | $1,273 |
| EBITDA | -$64,757 | -$56,971 | -$46,942 | -$4,350 |
| % Margin | -19,925.2% | -11,394.2% | -1,913.7% | -10.4% |